Edit

Israel Healthcare Ventures

https://ihcv.co.il/
Last activity: 30.10.2020
Invests in categories: MedTechHardwareRoboticsProductTechnologyHealthTechDeliveryDevelopmentDrugIT
News
39
Portfolio
16
Employees: 1-10

Portfolio 16

Show more

News 39

DateTitleDescription
-Gamida Cell Announces Investment and Option Agreement with M...Jerusalem, Israel, August 19, 2014 — Gamida Cell, a world leader in stem cell expansion technologies...
-ReWalk Robotics announces Australian approval, distribution ...ReWalk Robotics has announced a collaboration with Making Strides, of Queensland, Australia. Making ...
-OrSense Introduces Glasswing, its Next-Generation, Wireless,...Cancun, Mexico, July 9, 2012 – OrSense Ltd., developer of monitors for non-invasive measurements of ...
-First Patient Successfully Transplanted with Cryopreserved (...Jerusalem, Israel, January 8, 2015 — Gamida Cell, a leader in cell therapy technologies and products...
-D-Pharm announces expected date of interim report for the DP...D-Pharm Ltd., (TASE: DPRM) announced today that the interim report for the DP-b99 MACSI study is exp...
-Gamida Cell’s StemEx® Achieves Primary Endpoint in Phase II/...Jerusalem, Israel – Gamida Cell announced today that its flagship product, StemEx, reached its prima...
-ReWalk Announces First U.S. Private Insurance Coverage for P...Marlborough, MA — January 22, 2015 — Exoskeleton leader ReWalk Robotics announced today the first re...
-IDRI and Medicago to present data at the World Vaccine Congr...SEATTLE, WA, and QUEBEC CITY, QC, April 9, 2013 – IDRI (Infectious Disease Research Institute), a Se...
-This Version of the ReWalk Personal Exoskeleton Offers Users...YOKNEAM ILIT, ISRAEL / MARLBOROUGH, MASSACHUSETTS, July 14, 2015 — ReWalk Robotics Ltd. (Nasdaq: RWL...
-D Pharm expands Chinese cooperation agreement. The agreement...D-Pharm Ltd. (TASE: DPRM) has expanded its commercialization agreement with China’s Wanbang Biopharm...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In